Hyperhomocysteinemia as an Independent Risk Factor for Coronary Heart Disease. Comparison with Conventional Risk

R Muzaffar1, M A Khan2, M H Mushtaq3

  • 1Rashid Latif Medical College, Department of Nutritional Sciences, Lahore, Pakistan.

Insights

Elevated plasma homocysteine is a significant independent risk factor for coronary heart disease (CHD). This finding suggests homocysteine levels can predict future cardiovascular disease (CVD) risk, even beyond traditional factors.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Epidemiology

Background:

  • Coronary heart disease (CHD) remains a leading cause of mortality worldwide.
  • Identifying novel risk factors independent of conventional ones is crucial for effective prevention strategies.
  • Elevated plasma homocysteine has been investigated as a potential contributor to cardiovascular disease (CVD).

Purpose of the Study:

  • To evaluate the association between raised plasma homocysteine concentrations and coronary heart disease (CHD).
  • To determine if plasma homocysteine is an independent risk factor for CHD, irrespective of traditional risk factors.
  • To assess the predictive value of plasma homocysteine for future cardiovascular events.

Main Methods:

  • A case-control study involving 210 subjects (105 CHD cases, 105 healthy controls) aged 25-60 years.
  • Plasma homocysteine levels were measured using fluorescence polarization immunoassay (FPIA).
  • Conventional risk factors (age, sex, family history, hypertension, smoking, physical activity) were assessed and compared between groups.

Main Results:

  • Mean plasma homocysteine levels were significantly higher in CHD cases (22.33±9.22 µmol/L) compared to controls (12.59±3.73 µmol/L) (p<0.001).
  • Logistic regression analysis revealed a strong association between hyperhomocysteinemia and CHD (OR 7.45), which persisted in multivariate analysis (OR 7.10).
  • Elevated homocysteine was confirmed as an independent risk factor for CHD, independent of conventional risk factors.

Conclusions:

  • Elevated plasma homocysteine is a significant and independent risk factor for coronary heart disease.
  • Plasma homocysteine levels can serve as a valuable biomarker for predicting the future risk of cardiovascular disease (CVD).
  • This finding supports the potential role of homocysteine-lowering strategies in CHD prevention.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
510
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
265
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
405
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
94
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
119
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.0K